Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies

GlaxoSmithKline · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
cancerdissolutionpharmacokinetics
cancer, gsk1120212, dmso content, pharmacokinetics, solid tumors, mek inhibitor, dissolution, trametinib, relative bioavailability, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 918980
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.